Clinical Trials
51 trialsA Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy
Eli Lilly and Company
MISOGLIO
University Hospital, Bordeaux
EViDENCE-BT
University of Zurich
Ultralow Dose PET Imaging of 18F-FDOPA
Nuclear Imaging Institute
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
M.D. Anderson Cancer Center
9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
AflacST1502
Emory University
HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
Pediatric Brain Tumor Consortium
Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)
Medical University of South Carolina
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
Reveal Pharmaceuticals Inc.
DOSINDYGO
University Hospital, Lille
Pembro+Chemo in Brain Mets
University of Kentucky
Carboplatin and Bevacizumab for Recurrent Ependymoma
National Institutes of Health Clinical Center (CC)
Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma
University of Milano Bicocca
Preventative Skin Care for Children Undergoing Targeted CNS Tumor Therapy
Dana-Farber Cancer Institute
Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
Pfizer
IG-SRS
University of California, San Diego
UVA-Gen001
University of Virginia
A Pilot RCT of the PRISM Intervention for AYAs With Cancer
Seattle Children's Hospital
Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers
Novartis
ALpha-T
Hoffmann-La Roche
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
TVAX Biomedical
Poly-ICLC
Wake Forest University Health Sciences
RAD0102
University of Alabama at Birmingham
OPTIMUM
Jubilant DraxImage Inc.
CAPTIVE
DNAtrix, Inc.
Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas
Memorial Sloan Kettering Cancer Center
Study of DC Vaccination Against Glioblastoma
Huashan Hospital
ReACT
Celldex Therapeutics
Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer
Novartis
OPTIMAL
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors
University of California, San Francisco
GW572016 to Treat Recurrent Malignant Brain Tumors
National Institutes of Health Clinical Center (CC)
Observation for Patients With Asymptomatic CNS Metastatic Disease
The Cooper Health System
Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
Masonic Cancer Center, University of Minnesota
A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation
University of Michigan Rogel Cancer Center
NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer
University of Kentucky
Combination of Hydroxyurea and Verapamil for Refractory Meningiomas
University of Utah
Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)
China Medical University Hospital
Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases
Memorial Sloan Kettering Cancer Center
Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors
National Institutes of Health Clinical Center (CC)
Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma
The Hospital for Sick Children
Phase II Study of SOM230 in Patients With Recurrent or Progressive Meningioma
University of Utah
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer
National Cancer Institute (NCI)
Exclusive Hypofractionated Stereotactic Radiotherapy in Non-resectable Single Brain Metastasis
Barretos Cancer Hospital
Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma
Isarna Therapeutics GmbH
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
National Cancer Institute (NCI)
Doxo
University Hospital Muenster
Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant
European Organisation for Research and Treatment of Cancer - EORTC
Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
Fred Hutchinson Cancer Center